Milestone Pharmaceuticals Inc. (MIST) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 169.44M |
| Enterprise Value | 154.77M |
| P/E Ratio | -1.53 |
| PEG Ratio | -0.07 |
| Price/Sales Ratio | 56.06 |
| Price/Book Ratio | 8.03 |
| Enterprise/Revenue | 9.26 |
| Enterprise/EBITDA | -0.3 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -35.86 |
| Operating Margin | -33.53 |
| Return On Assets | -0.46 |
| Return On Equity | -2.88 |
| Revenue | 1.55M |
| Revenue/Share | 0.02 |
| Gross Profit | 1.43M |
| EBITDA | -59.45M |
| Net Income | -63.06M |
| Diluted EPS | -0.75 |
| Total Cash | 170.61M |
| Total Cash/Share | 1.23 |
| Total Debt | 60.07M |
| Total Debt/Equity | 3.3 |
| Current Ratio | 8.13 |
| Book Value Per Share | 0.13 |
| 52-Week Change | -37.94 |
| 52-Week High | 3.06 |
| 52-Week Low | 1 |
| Moving Average 50 Days | 1.21 |
| Moving Average 200 Days | 1.7 |
| Average Volume | 1.43M |
| Shares Outstanding | 124.5M |
| % Held by Institutions | 47.12 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |